← Eichor
Condition: 18 Years And Older Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: 18 Years And Older

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

A Study to Learn About the Study Medicine PF-08052667 in People With Bladder Cancer
Phase 1 · 68 location(s) · Pfizer · NCT07206225A Study to Investigate the Efficacy, Safety, and Pharmacokinetics of Oral Rilzabrutinib Compared With Placebo in Partici
Phase 3 · 95 location(s) · Sanofi · NCT07086976A Study on the Immune Response and Safety of Vaccine Against Respiratory Syncytial Virus Given to Chinese Adults 18 to 5
Phase 3 · 15 location(s) · GlaxoSmithKline · NCT07220109VRC 900: Evaluation of Tissue-Specific Immune Responses in Adults 18 Years of Age and Older
Phase N/A · 1 location(s) · National Institute of Allergy and Infectious Diseases (NIAID · NCT01132859Clinical Trial of Recombinant RSV Vaccine (CHO Cell) (Adjuvanted) in Chinese Population Aged 18 Years and Older.
Phase 1/Phase 2 · 1 location(s) · Ab&B Bio-tech Co., Ltd.JS · NCT07582796A Randomized Clinical Trial Investigating the Safety, Reactogenicity, and Immunogenicity After Immunization With an mRNA
Phase 2 · 6 location(s) · BioNTech SE · NCT07379580RSV Vaccination in Immunocompromised Patients.
Phase 2 · 1 location(s) · Medical University of Vienna · NCT06597916A Study to Assess the Safety, Reactogenicity, and Immunogenicity of SK Japanese Encephalitis Messenger Ribonucleic Acid
Phase 1/Phase 2 · 3 location(s) · SK Bioscience Co., Ltd. · NCT06680128A Study of ORX142 in Healthy Adult Subjects, Including Subjects 18 to 80 Years of Age
Phase 1 · 3 location(s) · Centessa Pharmaceuticals (UK) Limited · NCT07082829A Study of Investigational RSV/hMPV Combination and Investigational hMPV Vaccines in Younger and Older Adults
Phase 1/Phase 2 · 4 location(s) · GlaxoSmithKline · NCT07628049A Study to Select a Dose Regimen (Part A) and to Investigate Overall Survival (Part B) With Nanvuranlat Compared With Ph
Phase 3 · 18 location(s) · J-Pharma Co., Ltd. · NCT07265674A Phase I/II, Dose-finding Study to Assess the Safety, Reactogenicity, and Immunogenicity of a Broadly Protective Sarbec
Phase 1/Phase 2 · 2 location(s) · SK Bioscience Co., Ltd. · NCT07280858Preoperative Genicular Radiofrequency and Functional Outcomes After Total Knee Arthroplasty
NA · 1 location(s) · Anesthesiology department Iris South Hospitals · NCT07727551Phase 1/2 Study of a Plant-Based Seasonal Recombinant Trivalent VLP Influenza Vaccine
Phase 1/Phase 2 · 7 location(s) · Aramis Biotechnologies Inc. · NCT07291635A Study to Investigate the Safety of DSP-3077 After a Unilateral Eye Injection in Male and Female Participants 18 Years
Phase 1/Phase 2 · 2 location(s) · Sumitomo Pharma America, Inc. · NCT06891885A Study to Learn About mRNA Vaccines Against Influenza in Adults
Phase 2 · 15 location(s) · Pfizer · NCT07431853A Study to Learn About the Safety of Taking an Additional Dose of the Medicine Rimegepant in Adults With Migraine
Phase 4 · 11 location(s) · Pfizer · NCT07609914
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.